PNTG
PNTG
The Pennant Group, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $289.32M ▲ | $19.34M ▼ | $8.64M ▲ | 2.99% ▲ | $0.25 ▲ | $19.88M ▲ |
| Q3-2025 | $229.04M ▲ | $35.92M ▲ | $6.08M ▼ | 2.66% ▼ | $0.18 ▼ | $12.48M ▼ |
| Q2-2025 | $219.5M ▲ | $18.77M ▲ | $7.08M ▼ | 3.23% ▼ | $0.21 ▼ | $14.01M ▼ |
| Q1-2025 | $209.84M ▲ | $16.73M ▲ | $7.78M ▲ | 3.71% ▲ | $0.23 ▲ | $14.47M ▲ |
| Q4-2024 | $188.89M | $15.77M | $5.76M | 3.05% | $0.17 | $11.08M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $17.02M ▲ | $968.18M ▲ | $593.93M ▲ | $332.6M ▲ |
| Q3-2025 | $2.34M ▼ | $753.64M ▲ | $410.6M ▼ | $321.91M ▲ |
| Q2-2025 | $14.38M ▲ | $751.42M ▲ | $417.79M ▼ | $313.3M ▲ |
| Q1-2025 | $5.22M ▼ | $743.62M ▲ | $420.6M ▲ | $303.6M ▲ |
| Q4-2024 | $24.25M | $679.52M | $367.56M | $293.28M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $25.02M ▲ | $20.96M ▲ | $-153.02M ▼ | $146.75M ▲ | $14.69M ▲ | $13.97M ▲ |
| Q3-2025 | $6.08M ▼ | $13.92M ▼ | $-14.6M ▼ | $-11.38M ▲ | $-12.05M ▼ | $10.47M ▼ |
| Q2-2025 | $7.98M ▲ | $34.64M ▲ | $-10.05M ▲ | $-15.43M ▼ | $9.16M ▲ | $31.58M ▲ |
| Q1-2025 | $7.78M ▲ | $-21.23M ▼ | $-50.3M ▼ | $52.51M ▲ | $-19.02M ▼ | $-23.19M ▼ |
| Q4-2024 | $6.53M | $20.57M | $-4.4M | $3.61M | $19.78M | $17.25M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Home Health And Hospice Services Segment | $160.00M ▲ | $170.00M ▲ | $170.00M ▲ | $230.00M ▲ |
Senior Living Services Segment | $50.00M ▲ | $50.00M ▲ | $60.00M ▲ | $60.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at The Pennant Group, Inc.'s financial evolution and strategic trajectory over the past five years.
Pennant shows a combination of solid current profitability, strong cash generation, and a distinctive operating model. The company runs its overhead leanly, converts earnings into cash effectively, and has built a sizable asset and equity base over time. Its decentralized structure, cultural focus, and investment in data and analytics provide a clear strategic identity in the home health, hospice, and senior living space. Leadership development, proven acquisition capabilities, and growing partnerships with health systems and technology providers further support its ability to scale.
The main concerns center on financial leverage, thin margins, and execution demands. High debt relative to equity and assets, together with only modest liquidity, leaves the business more vulnerable to shocks in reimbursement, labor costs, or referral volumes. Profit margins are positive but not generous, limiting the buffer for error in a heavily regulated and labor-intensive industry. An aggressive acquisition strategy, combined with substantial intangible assets, adds integration and impairment risk. Finally, innovation is mostly operational rather than patent-protected, so sustained advantage depends on consistent execution and cultural strength rather than exclusive technology.
The overall picture is of a company with a credible, differentiated model and healthy current performance, but one that is operating with a relatively tight financial and operational margin for error. If Pennant continues to execute well on acquisitions, maintains its culture, and leverages its technology partnerships and analytics to improve outcomes and efficiency, it is positioned to benefit from long-term trends such as population aging and the shift toward care in lower-cost settings. However, its elevated leverage and modest liquidity mean that careful balance sheet management and disciplined capital allocation will be critical, especially in the face of regulatory changes or economic slowdowns. With only one year of detailed financial data, confidence in long-term trends should remain cautious and focused on how these strategic themes play out over time.
About The Pennant Group, Inc.
https://www.pennantgroup.comThe Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $289.32M ▲ | $19.34M ▼ | $8.64M ▲ | 2.99% ▲ | $0.25 ▲ | $19.88M ▲ |
| Q3-2025 | $229.04M ▲ | $35.92M ▲ | $6.08M ▼ | 2.66% ▼ | $0.18 ▼ | $12.48M ▼ |
| Q2-2025 | $219.5M ▲ | $18.77M ▲ | $7.08M ▼ | 3.23% ▼ | $0.21 ▼ | $14.01M ▼ |
| Q1-2025 | $209.84M ▲ | $16.73M ▲ | $7.78M ▲ | 3.71% ▲ | $0.23 ▲ | $14.47M ▲ |
| Q4-2024 | $188.89M | $15.77M | $5.76M | 3.05% | $0.17 | $11.08M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $17.02M ▲ | $968.18M ▲ | $593.93M ▲ | $332.6M ▲ |
| Q3-2025 | $2.34M ▼ | $753.64M ▲ | $410.6M ▼ | $321.91M ▲ |
| Q2-2025 | $14.38M ▲ | $751.42M ▲ | $417.79M ▼ | $313.3M ▲ |
| Q1-2025 | $5.22M ▼ | $743.62M ▲ | $420.6M ▲ | $303.6M ▲ |
| Q4-2024 | $24.25M | $679.52M | $367.56M | $293.28M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $25.02M ▲ | $20.96M ▲ | $-153.02M ▼ | $146.75M ▲ | $14.69M ▲ | $13.97M ▲ |
| Q3-2025 | $6.08M ▼ | $13.92M ▼ | $-14.6M ▼ | $-11.38M ▲ | $-12.05M ▼ | $10.47M ▼ |
| Q2-2025 | $7.98M ▲ | $34.64M ▲ | $-10.05M ▲ | $-15.43M ▼ | $9.16M ▲ | $31.58M ▲ |
| Q1-2025 | $7.78M ▲ | $-21.23M ▼ | $-50.3M ▼ | $52.51M ▲ | $-19.02M ▼ | $-23.19M ▼ |
| Q4-2024 | $6.53M | $20.57M | $-4.4M | $3.61M | $19.78M | $17.25M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Home Health And Hospice Services Segment | $160.00M ▲ | $170.00M ▲ | $170.00M ▲ | $230.00M ▲ |
Senior Living Services Segment | $50.00M ▲ | $50.00M ▲ | $60.00M ▲ | $60.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at The Pennant Group, Inc.'s financial evolution and strategic trajectory over the past five years.
Pennant shows a combination of solid current profitability, strong cash generation, and a distinctive operating model. The company runs its overhead leanly, converts earnings into cash effectively, and has built a sizable asset and equity base over time. Its decentralized structure, cultural focus, and investment in data and analytics provide a clear strategic identity in the home health, hospice, and senior living space. Leadership development, proven acquisition capabilities, and growing partnerships with health systems and technology providers further support its ability to scale.
The main concerns center on financial leverage, thin margins, and execution demands. High debt relative to equity and assets, together with only modest liquidity, leaves the business more vulnerable to shocks in reimbursement, labor costs, or referral volumes. Profit margins are positive but not generous, limiting the buffer for error in a heavily regulated and labor-intensive industry. An aggressive acquisition strategy, combined with substantial intangible assets, adds integration and impairment risk. Finally, innovation is mostly operational rather than patent-protected, so sustained advantage depends on consistent execution and cultural strength rather than exclusive technology.
The overall picture is of a company with a credible, differentiated model and healthy current performance, but one that is operating with a relatively tight financial and operational margin for error. If Pennant continues to execute well on acquisitions, maintains its culture, and leverages its technology partnerships and analytics to improve outcomes and efficiency, it is positioned to benefit from long-term trends such as population aging and the shift toward care in lower-cost settings. However, its elevated leverage and modest liquidity mean that careful balance sheet management and disciplined capital allocation will be critical, especially in the face of regulatory changes or economic slowdowns. With only one year of detailed financial data, confidence in long-term trends should remain cautious and focused on how these strategic themes play out over time.

CEO
Brent J. Guerisoli
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 132
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
VAN BERKOM & ASSOCIATES INC.
Shares:3.12M
Value:$105.02M
BLACKROCK, INC.
Shares:2.71M
Value:$91.49M
BLACKROCK INC.
Shares:2.23M
Value:$75.07M
Summary
Showing Top 3 of 241

